Detalhe da pesquisa
1.
CD38 promotes hematopoietic stem cell dormancy.
PLoS Biol
; 22(2): e3002517, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422172
2.
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Blood
; 141(15): 1846-1857, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508705
3.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Br J Haematol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593353
4.
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype.
Cancer Immunol Immunother
; 73(1): 8, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231344
5.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
6.
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.
Blood
; 140(24): 2594-2610, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857899
7.
ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356460
8.
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Haematologica
; 109(2): 431-443, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646665
9.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654660
10.
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Ann Hematol
; 103(3): 993-997, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214707
11.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542108
12.
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.
Br J Haematol
; 201(2): 308-318, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573337
13.
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients less than 60 years of age: a prospective phase II study
Haematologica
; 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941409
14.
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Haematologica
; 108(9): 2305-2315, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951165
15.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708137
16.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815361
17.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
18.
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Transfusion
; 63(11): 2131-2139, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850414
19.
Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin.
Cell Commun Signal
; 21(1): 36, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788616
20.
Long-Term Observation of Patients With Cancer - an Entity-Independent Registry for Healthcare and Translational Research at the University Medicine Dresden (Cancer-Reg-VT). / Langzeitbeobachtung von Patienten mit Krebserkrankungen ein entitätsunabhängiges Register für Versorgungsforschung und translationale Forschung an der Universitätsmedizin Dresden (Cancer-Reg-VT).
Gesundheitswesen
; 85(S 03): S226-S234, 2023 Sep.
Artigo
em Inglês, Alemão
| MEDLINE | ID: mdl-37751759